Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julie S Deutsch"'
Autor:
Xiaowei Xu, Hao Wang, Michael Tetzlaff, James Ziai, Sabina Signoretti, Ashley Cimino-Mathews, Tricia Cottrell, Janis M Taube, Annikka Weissferdt, Richard A Scolyer, Pierre-Olivier Fiset, Jaime Rodriguez-Canales, Lynette M Sholl, Julie S Deutsch, Krista Chen, Carlos E de Andrea, Christine Orr, Salgado Roberto, Christian Schurch, Raja Seethala, Alexander S Baras
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/43e08721fce4413f885d76cce4d9f3a9
Autor:
Joshua Doyle, Benjamin F. Green, Margaret Eminizer, Daniel Jimenez-Sanchez, Steve Lu, Elizabeth L. Engle, Haiying Xu, Aleksandra Ogurtsova, Jonathan Lai, Sigfredo Soto-Diaz, Jeffrey S. Roskes, Julie S. Deutsch, Janis M. Taube, Joel C. Sunshine, Alexander S. Szalay
Publikováno v:
Laboratory Investigation. :100175
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edcf792a1e419a9f485bc4460bd22fe6
https://doi.org/10.1016/j.labinv.2023.100175
https://doi.org/10.1016/j.labinv.2023.100175
Autor:
Joel C. Sunshine, Tracee L. McMiller, Alyza Skaist, Yan Zhang, Alan Berger, Kornel Schuebel, Jennifer Meyers, Julie S. Deutsch, Aleksandra Ogurtsova, Elizabeth L. Engle, Leslie Cope, Janis M. Taube, Suzanne L. Topalian
Publikováno v:
Cancer Research. 83:2260-2260
Background: Neoadjuvant anti-PD-1-based therapies have shown promise in several cancers, including Merkel cell carcinoma (MCC), a rare and aggressive skin cancer. We have shown that on-treatment specimens from patients responding to anti-PD-1 are cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::567fe9be15b3e6757724424ccd06d9a0
https://doi.org/10.1158/1538-7445.am2023-2260
https://doi.org/10.1158/1538-7445.am2023-2260
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Autor:
Nirmish Singla, Thomas Nirschl, Aleksandar Obradovic, Eugene Shenderov, Kara A. Lombardo, Xiaopu Liu, Alice Pons, Jelani Zarif, Steven P. Rowe, Bruce J. Trock, Hans J. Hammers, Trinity Bivalacqua, Phillip Pierorazio, Julie S. Deutsch, Tamara L. Lotan, Janis M. Taube, Yasser Ged, Michael A. Gorin, Mohamad E. Allaf, Charles G. Drake
Publikováno v:
Journal of Clinical Oncology. 41:708-708
708 Background: Novel perioperative strategies are needed to reduce recurrence rates in patients undergoing nephrectomy for high-risk, non-metastatic clear cell renal cell carcinoma (ccRCC). We sought to (1) elucidate the effects of PD-1 inhibition o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ff825c8451963c840e7c25d1182b307
https://doi.org/10.1200/jco.2023.41.6_suppl.708
https://doi.org/10.1200/jco.2023.41.6_suppl.708
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Autor:
Nirmish Singla, Thomas R. Nirschl, Aleksandar Z. Obradovic, Eugene Shenderov, Kara Lombardo, Xiaopu Liu, Alice Pons, Jelani C. Zarif, Steven P. Rowe, Bruce J. Trock, Hans J. Hammers, Trinity J. Bivalacqua, Phillip M. Pierorazio, Julie S. Deutsch, Tamara L. Lotan, Janis M. Taube, Yasser M. A. Ged, Michael A. Gorin, Mohamad E. Allaf, Charles G. Drake
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Novel perioperative strategies are needed to reduce recurrence rates in patients undergoing nephrectomy for high-risk, non-metastatic clear cell renal cell carcinoma (ccRCC). We conducted a prospective, phase I trial of neoadjuvant nivolumab
Externí odkaz:
https://doaj.org/article/98ed340a1cfb40a2a956efc49983a1b8